Today: 21 May 2026

Michał Rogucki

Stock market today: Dow, S&P 500 futures steady as Iran war keeps oil in focus; bitcoin jumps back to $74,000

Stock market today: Dow, S&P 500 futures steady as Iran war keeps oil in focus; bitcoin jumps back to $74,000

U.S. stock futures were little changed early Thursday as the U.S.-Israeli air war with Iran entered its sixth day, keeping focus on oil and inflation. Dow futures slipped 0.16%, S&P 500 futures edged down 0.01%. Oil prices rose, with Brent at $83.12 a barrel. Bitcoin hit a one-month high as traders watched Washington’s crypto bill debate.
5 March 2026
··
Hong Kong’s 2,000-Tonne Gold Vault Plan Gets Fresh Incentives as China Eyes Bullion Pricing Power

Hong Kong’s 2,000-Tonne Gold Vault Plan Gets Fresh Incentives as China Eyes Bullion Pricing Power

Hong Kong will offer support for gold refiners seeking LBMA certification and boost cross-border trade with mainland China, InvestHK said Thursday. The government aims to raise storage capacity to over 2,000 metric tons within three years. Beijing plans to manage overcapacity in heavy industries and expand strategic mineral stockpiles. China has increased gold reserves for 15 consecutive months through January.
5 March 2026
·
South Korea’s KOSPI jumps 10% as Iran war lifts oil toward $84 and rattles global markets

South Korea’s KOSPI jumps 10% as Iran war lifts oil toward $84 and rattles global markets

South Korea’s KOSPI surged nearly 10% after President Lee Jae Myung activated a $68 billion market stabilisation fund. Brent crude briefly topped $84 a barrel as Iran’s missile attack on Israel disrupted shipping, halting tanker traffic in the Strait of Hormuz. Bond yields and the dollar rose as traders scaled back expectations for near-term rate cuts. Qatar declared force majeure on gas exports, warning of at least a month’s disruption.
5 March 2026
·
Ondas Inc lands $20 million border drone order as national autonomous program kicks off

Ondas Inc lands $20 million border drone order as national autonomous program kicks off

Ondas Inc’s Airobotics unit received a $20 million initial purchase order as prime contractor for a national border-protection drone program, triggering development and phased deployment. The company has not disclosed the customer or country. Shares closed up 4.9% at $10.51 on Wednesday. The order is part of a multi-year framework and involves integrating drones, software, and ground infrastructure.
5 March 2026
··
AppLovin hints at upside in gaming-ads growth target as investors look for a new catalyst

AppLovin hints at upside in gaming-ads growth target as investors look for a new catalyst

AppLovin CFO Matt Stumpf said the company sees “potential upside” to its 20%-30% gaming ad growth target at a Morgan Stanley conference, a day after shares jumped about 10%. AppLovin-owned Adjust reported Tripledot Studios moved over 30 live games to its platform without disrupting campaigns. AppLovin posted $1.658 billion in Q4 revenue and guided Q1 revenue between $1.745 billion and $1.775 billion.
5 March 2026
·
Marvell earnings today: What could swing MRVL stock after the bell

Marvell earnings today: What could swing MRVL stock after the bell

Marvell Technology shares rose 0.8% to $78.09 in premarket trading Thursday ahead of its earnings report due after the U.S. market close. Analysts expect adjusted earnings of 79 cents a share on $2.21 billion in revenue, up from a year ago. Options traders are pricing an 11% swing in the stock after results. Marvell completed its XConn Technologies purchase in February, expecting revenue contribution in fiscal 2027.
5 March 2026
··
Astera Labs stock in focus after insider sale filing and fresh margin headwind talk

Astera Labs stock in focus after insider sale filing and fresh margin headwind talk

Astera Labs general counsel Philip Mazzara sold 10,000 shares for about $1.17 million on March 2, according to a Form 4 filing. CEO Jitendra Mohan downplayed concerns over a potential AI spending slowdown in 2027. CFO Mike Tate warned of a 200-basis-point gross margin headwind starting in the June quarter, citing an Amazon warrant and product mix. Shares rose 3.6% in premarket trading Thursday.
5 March 2026
·
BW stock jumps after Babcock & Wilcox gets $2.4 billion green light to build AI data-center power project

BW stock jumps after Babcock & Wilcox gets $2.4 billion green light to build AI data-center power project

Babcock & Wilcox received full notice to proceed on a $2.4 billion contract to supply equipment for Applied Digital’s AI data center campuses. The deal includes four 300-megawatt natural gas-fired boiler and generator systems. Shares rose nearly 31% after B&W reported fourth-quarter revenue of $161 million, beating analyst estimates. A securities filing set a fixed fee of about $434.8 million plus variable charges.
5 March 2026
···
Veeva earnings: $3.6 billion outlook and buyback plan as AI agents roll out

Veeva earnings: $3.6 billion outlook and buyback plan as AI agents roll out

Veeva Systems reported fourth-quarter revenue up 16% to $836 million and adjusted earnings of $2.06 per share, beating analyst expectations. The company forecast fiscal 2027 revenue of $3.585 billion to $3.6 billion and launched a $2 billion share buyback, purchasing $180 million in stock in the quarter. Cash and short-term investments totaled $6.6 billion at year-end.
5 March 2026
···
Firefly Neuroscience stock jumps 126% after Nvidia GPU push and 33-fold brain-scan surge

Firefly Neuroscience stock jumps 126% after Nvidia GPU push and 33-fold brain-scan surge

Firefly Neuroscience reported a 33-fold jump in EEG/ERP brain scan volumes to over 10,800 in 2025 and expanded to 99 commercial users, up more than 20-fold. The company is deploying NVIDIA L40S GPUs to accelerate processing for a new AI “foundation model” built on EEG data. Shares closed at $1.55, up 126% in 24 hours. Growth followed the acquisition of Evoke Neuroscience and internal initiatives.
5 March 2026
··
1 … 3 4 5 6 7 … 27

Stock Market Today

  • 3 Middle Eastern Penny Stocks With Market Caps Over US$3M
    May 21, 2026, 12:54 AM EDT. Investors cautious amid geopolitical risks and volatile oil. Three Middle Eastern penny stocks spotlighted for strong financials despite challenges. Airtouch Solar Ltd (market cap ₪15.08M) cut losses 11% annually, with revenue of ₪38.03M but increased net loss of ₪8.12M, maintaining more cash than debt and a 3-year cash runway. Big Tech 50 R&D (market cap ₪10.75M) is pre-revenue, reducing net loss to $2.85M, debt-free with 3+ years cash runway, led by an experienced board. Sonovia Ltd (market cap ₪9.27M) develops anti-bacterial textiles, details limited in the report. These firms show potential in under-the-radar Middle Eastern markets amid uncertain environment.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop